These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22362231)

  • 21. Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials.
    Sadowsky CH; Farlow MR; Meng X; Olin JT
    Int J Clin Pract; 2010 Jan; 64(2):188-93. PubMed ID: 20089009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
    Aguglia E; Onor ML; Saina M; Maso E
    Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
    Seitz DP; Gill SS; Gruneir A; Austin PC; Anderson G; Reimer CL; Rochon PA
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):803-13. PubMed ID: 21873836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.
    Kurz A; Van Baelen B
    Dement Geriatr Cogn Disord; 2004; 18(2):217-26. PubMed ID: 15237280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of donepezil and rivastigmine.
    Gray R
    Int J Clin Pract; 2003 Jun; 57(5):449; author reply 449. PubMed ID: 12846358
    [No Abstract]   [Full Text] [Related]  

  • 26. [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].
    Schreiter Gasser U; Gasser T
    Fortschr Med Orig; 2001 Nov; 119(3-4):135-8. PubMed ID: 11789125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease.
    Wilkinson DG; Passmore AP; Bullock R; Hopker SW; Smith R; Potocnik FC; Maud CM; Engelbrecht I; Hock C; Ieni JR; Bahra RS
    Int J Clin Pract; 2002; 56(6):441-6. PubMed ID: 12166542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
    Allain-Veyrac G; Lebreton A; Collonnier C; Jolliet P
    Am J Clin Dermatol; 2011 Jun; 12(3):210-3. PubMed ID: 21469764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
    Dybicz SB; Keohane DJ; Erwin WG; McRae T; Shah SN
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):154-60. PubMed ID: 16860262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
    Starr JM
    J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206
    [No Abstract]   [Full Text] [Related]  

  • 32. Dementia medications in palliative care #174.
    Morrison LJ; Liao S
    J Palliat Med; 2008 May; 11(4):634-5. PubMed ID: 18454618
    [No Abstract]   [Full Text] [Related]  

  • 33. Pisa syndrome due to donepezil: pharmacokinetic interactions to blame?
    Pollock D; Cunningham E; McGuinness B; Passmore AP
    Age Ageing; 2017 May; 46(3):529-530. PubMed ID: 28104598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment persistency with rivastigmine and donepezil in a large state medicaid program.
    Singh G; Thomas SK; Arcona S; Lingala V; Mithal A
    J Am Geriatr Soc; 2005 Jul; 53(7):1269-70. PubMed ID: 16108961
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
    Cumbo E; Ligori LD
    J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute dystonic reaction with rivastigmine.
    Dhikav V; Anand KS
    Int Psychogeriatr; 2013 Aug; 25(8):1385-6. PubMed ID: 23561545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
    Hernandez RK; Farwell W; Cantor MD; Lawler EV
    J Am Geriatr Soc; 2009 Nov; 57(11):1997-2003. PubMed ID: 19793162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dementia.
    Warner J; Butler R; Arya P
    Clin Evid; 2004 Jun; (11):1250-77. PubMed ID: 15652059
    [No Abstract]   [Full Text] [Related]  

  • 40. The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies.
    Simard M; van Reekum R
    J Neuropsychiatry Clin Neurosci; 2004; 16(4):409-25. PubMed ID: 15616167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.